prospective [resa]
Evaluation [ftcn]
lipoprotein-associated phospholipase A(2) [aapp, enzy]
Levels [qlco]
Future [tmco]
cardiovascular events [fndg]
Women [popg]
objectives [inpr]
lipoprotein-associated phospholipase A(2) [aapp, enzy]
Lp-PLA(2) [aapp, enzy]
Future [tmco]
CARDIOVASCULAR [bdsy]
Women [popg]
Inflammatory [ftcn]
Marker [clna]
Help [socb]
CARDIOVASCULAR [bdsy]
Lp-PLA(2) [aapp, enzy]
Levels [qlco]
Recently [tmco]
Independent [idcn]
CARDIOVASCULAR [bdsy]
Men [popg]
Methods [inpr]
Conduct [inbe]
prospective [resa]
Nested Case-control Study [resa]
Health [idcn]
Middle Aged [aggp]
Women [popg]
coronary heart disease [dsyn]
Fatal [qlco]
Myocardial Infarction [dsyn]
Stroke [dsyn]
baseline [bodm]
Lp-PLA(2) [aapp, enzy]
univariate analysis [resa]
Levels [qlco]
Lp-PLA(2) [aapp, enzy]
Correlated [qlco]
Low Density Lipoprotein Cholesterol [bacs, strd]
R- [spco]
P NOS [aapp, imft]
Women [popg]
Currently [tmco]
Hormone replacement therapy [topp]
mg/L [qnco]
mg/L [qnco]
P NOS [aapp, imft]
baseline [bodm]
Cases [ftcn]
N NOS [aapp, imft]
N NOS [aapp, imft]
mg/L [qnco]
mg/L [qnco]
P NOS [aapp, imft]
0.016" [qnco]
Predictive Value [qlco]
Lp-PLA(2) [aapp, enzy]
Markedly [qlco]
Attenuated [qlco]
Adjustment [inbe]
cardiovascular risk factor [dsyn]
Risks, Relative [qnco]
Future [tmco]
cardiovascular events [fndg]
Women [popg]
Lowest [qlco]
Referent [cnce]
Highest [qlco]
Quartile [qlco]
Lp-PLA(2) [aapp, enzy]
P-Value [qnco]
Contrast [qlco]
Adjusted [ftcn]
Risks, Relative [qnco]
Future [tmco]
cardiovascular events [fndg]
Increasing [ftcn]
Quartile [qlco]
C-reactive protein [aapp, imft]
Marker [clna]
Low Grade [qlco]
Inflammation [patf]
P-Value [qnco]
trend [tmco]
Inclusion [qlco]
Lp-PLA(2) [aapp, enzy]
Levels [qlco]
Attenuate [acty]
Conclusions [idcn]
Prior [tmco]
Men [popg]
Current [tmco]
Suggest [idcn]
Lp-PLA(2) [aapp, enzy]
Strong [qlco]
Future [tmco]
CARDIOVASCULAR [bdsy]
Women [popg]
COLL [inpr]
American [popg]
College [mnob]
Cardiology [bmod]
